128702-03-4 Usage
Explanation
This is the full chemical name of the compound, which describes its structure and the presence of a 2,3-dihydro ring.
Explanation
The Chemical Abstracts Service (CAS) number is a unique identifier for this specific chemical compound.
Explanation
This is the chemical formula for the compound, indicating the number of carbon (C), hydrogen (H), nitrogen (N), and oxygen (O) atoms present in a single molecule.
Explanation
The compound has a ring structure consisting of a pyrido (a type of indole ring) and an oxazin (a type of oxazine ring) fused together.
Explanation
The compound exists in a 2,3-dihydro form, which means it has two hydrogen atoms added to the ring structure, typically resulting in a more stable and reduced form of the molecule.
Explanation
The compound is an amine derivative, which means it contains an amine functional group (-NH2) attached to a carbon chain.
Explanation
1H-Pyrido[2,3-b][1,4]oxazin-8-amine, 2,3-dihydromay have potential uses in the pharmaceutical industry, organic synthesis, and scientific research, although its specific applications and properties are still being studied.
Explanation
Researchers and regulatory agencies are currently investigating the specific uses, properties, and potential hazards of this chemical compound to better understand its potential applications and safety.
Structure
Pyrido-oxazin ring
Form
2,3-dihydro
Type
Amine derivative
Potential Applications
Pharmaceuticals, organic synthesis, research
Ongoing Research
Specific uses, properties, and potential hazards
Check Digit Verification of cas no
The CAS Registry Mumber 128702-03-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,7,0 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 128702-03:
(8*1)+(7*2)+(6*8)+(5*7)+(4*0)+(3*2)+(2*0)+(1*3)=114
114 % 10 = 4
So 128702-03-4 is a valid CAS Registry Number.
128702-03-4Relevant academic research and scientific papers
MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS
-
Page/Page column 105, (2019/05/02)
The invention provides compounds of formula (I) or pharmaceutically acceptable salt thereof wherein ring A represents group A-I, A-II or A-III. Al represents -C(R4a)(R4a)-, -C(R4a)= -N(R4b)-, -N= -O- or -S-; A2 represents -C(R4c)(R4c)-, -C(R4c)= or -0-; A3 represents -C(R4c)(R4c)-, -C(R4c)= or -0-; A4 represents -C(R4a)(R4a)-, -C(R4a)= -N= -O- or -S-; A5 represents -C(R4a)(R4a)-, -C(R4a)= -N(R4b)-, -N= -O- or -S-; A6 represents -C(R4c)(R4c)- or -C(R4c)=; A7 represents -C(R4a)(R4a)-, -C(R4a)= -N= -O- or -S-; A8 represents -C(R4a)(R4a)-, -N(R4b)-, -O- or -S-; A9 represents -C(R4c)(R4c)- or -0-; A10 represents -C(R4c)(R4c)- or -0-; A11 represents -C(R4c)(R4c)- or -0-; A12 represents -C(R4a)(R4a)-, -O- or -S-; wherein group A-I, group A-II and group A-III de not contain adjacent oxygen atoms, adjacent oxygen and sulfur atoms or adjacent oxygen and nitrogen atoms or a moiety selected from the group consisting of N-C-N, N-C-S, S-C-S, O-C-N, O-C-O and O-C-S, wherein in each case the carbon atom in the N-C-N, N-C-S, S-C-S, O-C-N, O-C-O and O-C-S moiety is saturated; B1, B2, B3 and B4 represent independently C(R3) or N, wherein no more than two of B1, B2, B3 and B4 represent N; n is 1 or 2; and R1, R2, R3, R4a, R4b and R4c are as defined in the claims, as well as methods of using the compounds to treat proliferation diseases, in particular cancer.
